IN8bio, Inc. (INAB) Misses Q2 EPS by 118c
Tweet
Share
E-mailGet Alerts INAB Hot Sheet
Join SI Premium – FREE
IN8bio, Inc. (NASDAQ: INAB) reported Q2 EPS of ($1.24), $1.18 worse than the analyst estimate of ($0.06).
For earnings history and earnings-related data on IN8bio, Inc. (INAB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Insurance sector reversal may favor Allstate and Progressive
- Goldman Sachs Reinstates Kokusai Electric Corp (6525:JP) at Neutral
- Wells Fargo Previews Airbnb Inc. (ABNB) Earnings: 'Expect 2026 margin guide of "at least 35%" to hold despite'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
